Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2005 1
2006 3
2007 3
2008 2
2010 2
2011 3
2012 5
2013 5
2014 2
2015 4
2016 4
2017 7
2018 8
2019 9
2020 10
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Results by year
Filters applied: . Clear all
Page 1
Role of liver biopsy in hepatocellular carcinoma.
Di Tommaso L, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, Lleo A. Di Tommaso L, et al. Among authors: personeni n. World J Gastroenterol. 2019 Oct 28;25(40):6041-6052. doi: 10.3748/wjg.v25.i40.6041. World J Gastroenterol. 2019. PMID: 31686761 Free PMC article. Review.
Cabozantinib for the treatment of hepatocellular carcinoma.
Personeni N, Rimassa L, Pressiani T, Smiroldo V, Santoro A. Personeni N, et al. Expert Rev Anticancer Ther. 2019 Oct;19(10):847-855. doi: 10.1080/14737140.2019.1674141. Epub 2019 Oct 11. Expert Rev Anticancer Ther. 2019. PMID: 31603008 Review.
Systemic treatment of HCC in special populations.
Rimassa L, Personeni N, Czauderna C, Foerster F, Galle P. Rimassa L, et al. Among authors: personeni n. J Hepatol. 2021 Apr;74(4):931-943. doi: 10.1016/j.jhep.2020.11.026. Epub 2020 Nov 26. J Hepatol. 2021. PMID: 33248171 Review.
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options.
Personeni N, Lleo A, Pressiani T, Colapietro F, Openshaw MR, Stavraka C, Pouptsis A, Pinato DJ, Rimassa L. Personeni N, et al. Cancers (Basel). 2020 Nov 13;12(11):3370. doi: 10.3390/cancers12113370. Cancers (Basel). 2020. PMID: 33202975 Free PMC article. Review.
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
Mazzaferro V, El-Rayes BF, Droz Dit Busset M, Cotsoglou C, Harris WP, Damjanov N, Masi G, Rimassa L, Personeni N, Braiteh F, Zagonel V, Papadopoulos KP, Hall T, Wang Y, Schwartz B, Kazakin J, Bhoori S, de Braud F, Shaib WL. Mazzaferro V, et al. Among authors: personeni n. Br J Cancer. 2019 Jan;120(2):165-171. doi: 10.1038/s41416-018-0334-0. Epub 2018 Nov 13. Br J Cancer. 2019. PMID: 30420614 Free PMC article.
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study.
Fessas P, Kaseb A, Wang Y, Saeed A, Szafron D, Jun T, Dharmapuri S, Rafeh Naqash A, Muzaffar M, Navaid M, Khan U, Lee C, Bulumulle A, Yu B, Paul S, Nimkar N, Bettinger D, Benevento F, Hildebrand H, Pressiani T, Abugabal YI, Personeni N, Huang YH, Rimassa L, Ang C, Marron T, Pinato DJ. Fessas P, et al. Among authors: personeni n. J Immunother Cancer. 2020 Aug;8(2):e001033. doi: 10.1136/jitc-2020-001033. J Immunother Cancer. 2020. PMID: 32868393 Free PMC article.
COVID-19 and liver cancer clinical trials: Not everything is lost.
D'Alessio A, Personeni N, Pressiani T, Bozzarelli S, Smiroldo V, Simonelli M, Lleo A, Santoro A, Rimassa L. D'Alessio A, et al. Among authors: personeni n. Liver Int. 2020 Jul;40(7):1541-1544. doi: 10.1111/liv.14532. Liver Int. 2020. PMID: 32433799 Free PMC article.
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study.
Rimassa L, Assenat E, Peck-Radosavljevic M, Pracht M, Zagonel V, Mathurin P, Rota Caremoli E, Porta C, Daniele B, Bolondi L, Mazzaferro V, Harris W, Damjanov N, Pastorelli D, Reig M, Knox J, Negri F, Trojan J, López López C, Personeni N, Decaens T, Dupuy M, Sieghart W, Abbadessa G, Schwartz B, Lamar M, Goldberg T, Shuster D, Santoro A, Bruix J. Rimassa L, et al. Among authors: personeni n. Lancet Oncol. 2018 May;19(5):682-693. doi: 10.1016/S1470-2045(18)30146-3. Epub 2018 Apr 3. Lancet Oncol. 2018. PMID: 29625879 Clinical Trial.
66 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page